Furthermore, triptolide also possesses anti-angiogenic effect by inhibiting VEGFA expression in human breast cancer MDA-MB-231 and Hs578T cells, and through COX-2 and VEGF down-regulation in human pancreatic cancer Panc-1 cells [436, 437]. The gene discussed is VEGFA; the disease is pancreatic neoplasm.